1. Home
  2. GPMT vs ITRM Comparison

GPMT vs ITRM Comparison

Compare GPMT & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPMT
  • ITRM
  • Stock Information
  • Founded
  • GPMT 2015
  • ITRM 2015
  • Country
  • GPMT United States
  • ITRM Ireland
  • Employees
  • GPMT N/A
  • ITRM N/A
  • Industry
  • GPMT Real Estate Investment Trusts
  • ITRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • GPMT Real Estate
  • ITRM Health Care
  • Exchange
  • GPMT Nasdaq
  • ITRM Nasdaq
  • Market Cap
  • GPMT 95.4M
  • ITRM 35.6M
  • IPO Year
  • GPMT 2017
  • ITRM 2018
  • Fundamental
  • Price
  • GPMT $2.10
  • ITRM $1.03
  • Analyst Decision
  • GPMT Buy
  • ITRM Strong Buy
  • Analyst Count
  • GPMT 3
  • ITRM 2
  • Target Price
  • GPMT $2.38
  • ITRM $7.00
  • AVG Volume (30 Days)
  • GPMT 488.0K
  • ITRM 536.8K
  • Earning Date
  • GPMT 05-06-2025
  • ITRM 05-13-2025
  • Dividend Yield
  • GPMT 9.26%
  • ITRM N/A
  • EPS Growth
  • GPMT N/A
  • ITRM N/A
  • EPS
  • GPMT N/A
  • ITRM N/A
  • Revenue
  • GPMT N/A
  • ITRM N/A
  • Revenue This Year
  • GPMT N/A
  • ITRM N/A
  • Revenue Next Year
  • GPMT $25.28
  • ITRM $108.39
  • P/E Ratio
  • GPMT N/A
  • ITRM N/A
  • Revenue Growth
  • GPMT N/A
  • ITRM N/A
  • 52 Week Low
  • GPMT $1.61
  • ITRM $0.81
  • 52 Week High
  • GPMT $4.50
  • ITRM $3.02
  • Technical
  • Relative Strength Index (RSI)
  • GPMT 55.36
  • ITRM 44.07
  • Support Level
  • GPMT $1.85
  • ITRM $0.88
  • Resistance Level
  • GPMT $2.32
  • ITRM $1.14
  • Average True Range (ATR)
  • GPMT 0.14
  • ITRM 0.10
  • MACD
  • GPMT 0.08
  • ITRM -0.01
  • Stochastic Oscillator
  • GPMT 78.01
  • ITRM 30.56

About GPMT Granite Point Mortgage Trust Inc.

Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: